183 related articles for article (PubMed ID: 26879641)
1. The reactivation of tabun-inhibited mutant AChE with Ortho-7: steered molecular dynamics and quantum chemical studies.
Lo R; Chandar NB; Ghosh S; Ganguly B
Mol Biosyst; 2016 Apr; 12(4):1224-31. PubMed ID: 26879641
[TBL] [Abstract][Full Text] [Related]
2. In silico studies on the role of mutant Y337A to reactivate tabun inhibited mAChE with K048.
Chandar NB; Ghosh S; Lo R; Banjo S; Ganguly B
Chem Biol Interact; 2015 Dec; 242():299-306. PubMed ID: 26494532
[TBL] [Abstract][Full Text] [Related]
3. Revealing the importance of linkers in K-series oxime reactivators for tabun-inhibited AChE using quantum chemical, docking and SMD studies.
Ghosh S; Chandar NB; Jana K; Ganguly B
J Comput Aided Mol Des; 2017 Aug; 31(8):729-742. PubMed ID: 28646405
[TBL] [Abstract][Full Text] [Related]
4. Can hydroxylamine be a more potent nucleophile for the reactivation of tabun-inhibited AChE than prototype oxime drugs? An answer derived from quantum chemical and steered molecular dynamics studies.
Lo R; Ganguly B
Mol Biosyst; 2014 Jul; 10(9):2368-83. PubMed ID: 24964273
[TBL] [Abstract][Full Text] [Related]
5. Influence of gauche effect on uncharged oxime reactivators for the reactivation of tabun-inhibited AChE: quantum chemical and steered molecular dynamics studies.
Ghosh S; Jana K; Ganguly B
J Comput Aided Mol Des; 2018 Jul; 32(7):793-807. PubMed ID: 29980922
[TBL] [Abstract][Full Text] [Related]
6. Counteracting tabun inhibition by reactivation by pyridinium aldoximes that interact with active center gorge mutants of acetylcholinesterase.
Kovarik Z; Maček Hrvat N; Kalisiak J; Katalinić M; Sit RK; Zorbaz T; Radić Z; Fokin VV; Sharpless KB; Taylor P
Toxicol Appl Pharmacol; 2019 Jun; 372():40-46. PubMed ID: 30978400
[TBL] [Abstract][Full Text] [Related]
7. Oxime-dipeptides as anticholinesterase, reactivator of phosphonylated-serine of AChE catalytic triad: probing the mechanistic insight by MM-GBSA, dynamics simulations and DFT analysis.
Chadha N; Tiwari AK; Kumar V; Lal S; Milton MD; Mishra AK
J Biomol Struct Dyn; 2015; 33(5):978-90. PubMed ID: 24805972
[TBL] [Abstract][Full Text] [Related]
8. Centrally acting oximes in reactivation of tabun-phosphoramidated AChE.
Kovarik Z; Maček N; Sit RK; Radić Z; Fokin VV; Barry Sharpless K; Taylor P
Chem Biol Interact; 2013 Mar; 203(1):77-80. PubMed ID: 22960624
[TBL] [Abstract][Full Text] [Related]
9. Quantum chemical and steered molecular dynamics studies for one pot solution to reactivate aged acetylcholinesterase with alkylator oxime.
Chandar NB; Lo R; Ganguly B
Chem Biol Interact; 2014 Nov; 223():58-68. PubMed ID: 25218671
[TBL] [Abstract][Full Text] [Related]
10. Mutant cholinesterases possessing enhanced capacity for reactivation of their phosphonylated conjugates.
Kovarik Z; Radić Z; Berman HA; Simeon-Rudolf V; Reiner E; Taylor P
Biochemistry; 2004 Mar; 43(11):3222-9. PubMed ID: 15023072
[TBL] [Abstract][Full Text] [Related]
11. Molecular modeling and in vitro reactivation study between the oxime BI-6 and acetylcholinesterase inhibited by different nerve agents.
Giacoppo JO; C C França T; Kuča K; da Cunha EF; Abagyan R; Mancini DT; Ramalho TC
J Biomol Struct Dyn; 2015 Sep; 33(9):2048-58. PubMed ID: 25407587
[TBL] [Abstract][Full Text] [Related]
12. Oxime-assisted reactivation of tabun-inhibited acetylcholinesterase analysed by active site mutations.
Katalinić M; Šinko G; Maček Hrvat N; Zorbaz T; Bosak A; Kovarik Z
Toxicology; 2018 Aug; 406-407():104-113. PubMed ID: 29772260
[TBL] [Abstract][Full Text] [Related]
13. In vitro reactivation of acetylcholinesterase using the oxime K027.
Kuca K; Kassa J
Vet Hum Toxicol; 2004 Feb; 46(1):15-8. PubMed ID: 14748409
[TBL] [Abstract][Full Text] [Related]
14. In silico pharmacophore model for tabun-inhibited acetylcholinesterase reactivators: a study of their stereoelectronic properties.
Bhattacharjee AK; Kuca K; Musilek K; Gordon RK
Chem Res Toxicol; 2010 Jan; 23(1):26-36. PubMed ID: 20028185
[TBL] [Abstract][Full Text] [Related]
15. Catalytic-site conformational equilibrium in nerve-agent adducts of acetylcholinesterase: possible implications for the HI-6 antidote substrate specificity.
Artursson E; Andersson PO; Akfur C; Linusson A; Börjegren S; Ekström F
Biochem Pharmacol; 2013 May; 85(9):1389-97. PubMed ID: 23376121
[TBL] [Abstract][Full Text] [Related]
16. In silico studies in probing the role of kinetic and structural effects of different drugs for the reactivation of tabun-inhibited AChE.
Lo R; Chandar NB; Kesharwani MK; Jain A; Ganguly B
PLoS One; 2013; 8(12):e79591. PubMed ID: 24312449
[TBL] [Abstract][Full Text] [Related]
17. Interactions between xylene-linked carbamoyl bis-pyridinium mono-oximes and organophosphates inhibited-AChE: a kinetic study.
Sharma R; Gupta B; Acharya J; Kaushik MP; Ghosh KK
Toxicology; 2014 Feb; 316():1-8. PubMed ID: 24345352
[TBL] [Abstract][Full Text] [Related]
18. Reactivation kinetics of a homologous series of bispyridinium bis-oximes with nerve agent-inhibited human acetylcholinesterase.
Worek F; von der Wellen J; Musilek K; Kuca K; Thiermann H
Arch Toxicol; 2012 Sep; 86(9):1379-86. PubMed ID: 22437842
[TBL] [Abstract][Full Text] [Related]
19. Mono-oxime bisquaternary acetylcholinesterase reactivators with prop-1,3-diyl linkage-Preparation, in vitro screening and molecular docking.
Musilek K; Komloova M; Holas O; Horova A; Pohanka M; Gunn-Moore F; Dohnal V; Dolezal M; Kuca K
Bioorg Med Chem; 2011 Jan; 19(2):754-62. PubMed ID: 21215642
[TBL] [Abstract][Full Text] [Related]
20. Catalytic Soman Scavenging by the Y337A/F338A Acetylcholinesterase Mutant Assisted with Novel Site-Directed Aldoximes.
Kovarik Z; Maček Hrvat N; Katalinić M; Sit RK; Paradyse A; Žunec S; Musilek K; Fokin VV; Taylor P; Radić Z
Chem Res Toxicol; 2015 May; 28(5):1036-44. PubMed ID: 25835984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
